CERAGON NETWORKS LTD·4

May 26, 7:43 AM ET

Ripstein David 4

4 · CERAGON NETWORKS LTD · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Ceragon (CRNT) Director David Ripstein Receives RSUs & Options

What Happened David Ripstein, a director of Ceragon Networks Ltd. (CRNT), was granted equity compensation in late May 2026. On 05/22/2026 and 05/23/2026 he received a total of 21,270 ordinary shares via fully vested RSUs (6,520 on 05/22 and 14,750 on 05/23) and was granted stock options covering 42,530 shares (13,030 on 05/22 and 29,500 on 05/23). All grants show a $0 acquisition price (these were awards/grants, not open-market purchases). The RSUs were fully vested and automatically settled into ordinary shares on their grant dates; the options were fully vested and immediately exercisable upon grant.

Key Details

  • Transaction dates: RSUs and option grants dated 05/22/2026 and 05/23/2026; Form 4 filed 05/26/2026 (Accession 0001976408-26-000482).
  • Price: $0.00 reported for all line items (standard for awards/grants).
  • Shares acquired (issued): 21,270 ordinary shares via RSU settlement (6,520 + 14,750).
  • Derivative securities granted: Options covering 42,530 shares (13,030 + 29,500); options were fully vested and immediately exercisable.
  • Shares owned after transaction: Not specified in the details provided.
  • Footnotes: F1–F2 confirm RSUs each convert to one share and were fully vested and auto-settled on their grant dates. F3–F4 confirm option grants were fully vested and immediately exercisable on grant dates.
  • Filing timeliness: Form filed 05/26/2026 for transactions on 05/22–05/23/2026; this appears to fall within the typical SEC Form 4 reporting window.

Context

  • RSUs settled into ordinary shares are compensation awards and do not reflect an open-market purchase; they typically result from company compensation plans.
  • The option grants are vested and exercisable, but the filing does not show any exercise or sale of the optioned shares—no cashless exercises or market sales were reported.
  • These transactions are disclosure of insider grants, not sales, and should be viewed as company compensation activity rather than an insider purchase/sell signal.

Insider Transaction Report

Form 4
Period: 2026-05-22
Transactions
  • Award

    Ordinary Shares

    [F1]
    2026-05-22+6,52032,010 total
  • Award

    Ordinary Shares

    [F2]
    2026-05-23+14,75046,760 total
  • Award

    Stock Option (Right to Buy)

    [F3]
    2026-05-22+13,03013,030 total
    Exercise: $2.79From: 2026-05-22Exp: 2032-05-22Ordinary Shares (13,030 underlying)
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-05-23+29,50029,500 total
    Exercise: $2.80From: 2026-05-23Exp: 2032-05-23Ordinary Shares (29,500 underlying)
Footnotes (4)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Ceragon Networks Ltd. (the "Company"). The RSUs were fully vested upon grant and were automatically settled in ordinary shares on the grant date 05/22/2026.
  • [F2]The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Ceragon Networks Ltd. (the "Company"). The RSUs were fully vested upon grant and were automatically settled in ordinary shares on the grant date 05/23/2026.
  • [F3]The Reporting Person was granted stock options to purchase ordinary shares of Ceragon Networks Ltd. (the "Company"). The options were fully vested and immediately exercisable on the grant date 05/22/2026
  • [F4]The Reporting Person was granted stock options to purchase ordinary shares of Ceragon Networks Ltd. (the "Company"). The options were fully vested and immediately exercisable on the grant date 05/23/2026
Signature
/s/ Netta Cohen on behalf of Oppenheimer Israel, as Attorney-in-fact|2026-05-26

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT